286 related articles for article (PubMed ID: 21742025)
1. Sponge-associated microbial Antarctic communities exhibiting antimicrobial activity against Burkholderia cepacia complex bacteria.
Papaleo MC; Fondi M; Maida I; Perrin E; Lo Giudice A; Michaud L; Mangano S; Bartolucci G; Romoli R; Fani R
Biotechnol Adv; 2012; 30(1):272-93. PubMed ID: 21742025
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the volatile profile of Antarctic bacteria by using solid-phase microextraction-gas chromatography-mass spectrometry.
Romoli R; Papaleo MC; de Pascale D; Tutino ML; Michaud L; LoGiudice A; Fani R; Bartolucci G
J Mass Spectrom; 2011 Oct; 46(10):1051-9. PubMed ID: 22012672
[TBL] [Abstract][Full Text] [Related]
3. Genomic analysis of three sponge-associated Arthrobacter Antarctic strains, inhibiting the growth of Burkholderia cepacia complex bacteria by synthesizing volatile organic compounds.
Orlandini V; Maida I; Fondi M; Perrin E; Papaleo MC; Bosi E; de Pascale D; Tutino ML; Michaud L; Lo Giudice A; Fani R
Microbiol Res; 2014; 169(7-8):593-601. PubMed ID: 24231161
[TBL] [Abstract][Full Text] [Related]
4. Draft genomes of three Antarctic Psychrobacter strains producing antimicrobial compounds against Burkholderia cepacia complex, opportunistic human pathogens.
Fondi M; Orlandini V; Perrin E; Maida I; Bosi E; Papaleo MC; Michaud L; Lo Giudice A; de Pascale D; Tutino ML; Liò P; Fani R
Mar Genomics; 2014 Feb; 13():37-8. PubMed ID: 24401162
[TBL] [Abstract][Full Text] [Related]
5. Bioactive volatile organic compounds from Antarctic (sponges) bacteria.
Papaleo MC; Romoli R; Bartolucci G; Maida I; Perrin E; Fondi M; Orlandini V; Mengoni A; Emiliani G; Tutino ML; Parrilli E; de Pascale D; Michaud L; Lo Giudice A; Fani R
N Biotechnol; 2013 Sep; 30(6):824-38. PubMed ID: 23619351
[TBL] [Abstract][Full Text] [Related]
6. Pseudoalteromonas haloplanktis produces methylamine, a volatile compound active against Burkholderia cepacia complex strains.
Sannino F; Parrilli E; Apuzzo GA; de Pascale D; Tedesco P; Maida I; Perrin E; Fondi M; Fani R; Marino G; Tutino ML
N Biotechnol; 2017 Mar; 35():13-18. PubMed ID: 27989956
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Activity of Monoramnholipids Produced by Bacterial Strains Isolated from the Ross Sea (Antarctica).
Tedesco P; Maida I; Palma Esposito F; Tortorella E; Subko K; Ezeofor CC; Zhang Y; Tabudravu J; Jaspars M; Fani R; de Pascale D
Mar Drugs; 2016 Apr; 14(5):. PubMed ID: 27128927
[TBL] [Abstract][Full Text] [Related]
8. Preliminary data on antibacterial activity of Echinacea purpurea-associated bacterial communities against Burkholderia cepacia complex strains, opportunistic pathogens of Cystic Fibrosis patients.
Chiellini C; Maida I; Maggini V; Bosi E; Mocali S; Emiliani G; Perrin E; Firenzuoli F; Mengoni A; Fani R
Microbiol Res; 2017 Mar; 196():34-43. PubMed ID: 28164789
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic interactions between psychrotrophic cultivable bacteria isolated from Antarctic sponges: a preliminary analysis.
Mangano S; Michaud L; Caruso C; Brilli M; Bruni V; Fani R; Lo Giudice A
Res Microbiol; 2009; 160(1):27-37. PubMed ID: 19013518
[TBL] [Abstract][Full Text] [Related]
10. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
Vanlaere E; Baldwin A; Gevers D; Henry D; De Brandt E; LiPuma JJ; Mahenthiralingam E; Speert DP; Dowson C; Vandamme P
Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
[TBL] [Abstract][Full Text] [Related]
11. Isolation, characterization and phylogeny of sponge-associated bacteria with antimicrobial activities from Brazil.
Santos OC; Pontes PV; Santos JF; Muricy G; Giambiagi-deMarval M; Laport MS
Res Microbiol; 2010 Sep; 161(7):604-12. PubMed ID: 20600863
[TBL] [Abstract][Full Text] [Related]
12. Draft genome sequence of the volatile organic compound-producing Antarctic bacterium Arthrobacter sp. strain TB23, able to inhibit cystic fibrosis pathogens belonging to the Burkholderia cepacia complex.
Fondi M; Orlandini V; Maida I; Perrin E; Papaleo MC; Emiliani G; de Pascale D; Parrilli E; Tutino ML; Michaud L; Lo Giudice A; Fani R
J Bacteriol; 2012 Nov; 194(22):6334-5. PubMed ID: 23105071
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria.
Van Acker H; Van Snick E; Nelis HJ; Coenye T
J Cyst Fibros; 2010 Dec; 9(6):450-4. PubMed ID: 20851061
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
[TBL] [Abstract][Full Text] [Related]
15. Use of the gyrB gene to discriminate among species of the Burkholderia cepacia complex.
Tabacchioni S; Ferri L; Manno G; Mentasti M; Cocchi P; Campana S; Ravenni N; Taccetti G; Dalmastri C; Chiarini L; Bevivino A; Fani R
FEMS Microbiol Lett; 2008 Apr; 281(2):175-82. PubMed ID: 18312571
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
[TBL] [Abstract][Full Text] [Related]
17. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.
Mahenthiralingam E; Baldwin A; Dowson CG
J Appl Microbiol; 2008 Jun; 104(6):1539-51. PubMed ID: 18217926
[TBL] [Abstract][Full Text] [Related]
18. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.
Herasimenka Y; Cescutti P; Impallomeni G; Campana S; Taccetti G; Ravenni N; Zanetti F; Rizzo R
J Cyst Fibros; 2007 Apr; 6(2):145-52. PubMed ID: 16860003
[TBL] [Abstract][Full Text] [Related]
19. PCR-based identification and characterization of Burkholderia cepacia complex bacteria from clinical and environmental sources.
Seo ST; Tsuchiya K
Lett Appl Microbiol; 2004; 39(5):413-9. PubMed ID: 15482431
[TBL] [Abstract][Full Text] [Related]
20. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
Kidd TJ; Douglas JM; Bergh HA; Coulter C; Bell SC
Res Microbiol; 2008 Apr; 159(3):194-9. PubMed ID: 18356026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
